Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes

Renin–angiotensin system (RAS) blockade by angiotensin-converting enzyme inhibitors (ACEis) or angiotensin-receptor blockers (ARBs) has been related to anemia in various situations. We aimed to investigate whether discontinuation of RAS inhibitors improves erythropoiesis in patients with lower-risk...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ther Adv Hematol
Päätekijät: Pavlidis, George, Papageorgiou, Sotirios G., Bazani, Efthimia, Bouchla, Anthi, Glezou, Eirini, Gkontopoulos, Konstantinos, Thomopoulos, Thomas, Pappa, Vasiliki, Vlahakos, Demetrios V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809530/
https://ncbi.nlm.nih.gov/pubmed/33489062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620720958299
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia